Locations:

Cancer

January 28, 2019/Cancer/Research

New Treatment Regimen Holds Promise for Patients with Mantle Cell Lymphoma

Novel drugs included in therapy

18-RHE-10377-Calabrese-Hero-Image-650x450pxl

January 22, 2019/Cancer

A Novel Tumor Board for Patients with Immune-Related Adverse Events

Collaborating to treat this emerging complication of CPI

January 22, 2019/Cancer

Study Validates Clinical Criteria for Very High-Risk Localized Prostate Cancer

Data analyzed from three centers

January 21, 2019/Basic & Translational Science

Gene Profile Test Holds Predictive Potential for Early Stage Melanoma Patients

Test helpful for SLN-negative, stage I to IIA and thin tumors

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 18, 2019/Basic & Translational Science

FDA Recognizes PTEN Variant Criteria

Earlier detection of certain cancers a likely result

19-LRI-044_Cheng-personal-mutanomes_CQD_650x450

January 16, 2019/Basic & Translational Science

Personal Mutanomes, Precision Oncology and Drug Discovery

Toward detailed, personalized maps of identified and interpreted genomic variation

January 15, 2019/Cancer/Research

New Chemotherapy Regimen Proves Effective in Treating Amyloidosis

Refractory patients respond to combination therapy

January 10, 2019/Cancer/Research

Efficacy of a First-in-Class SMARCA5/CHD4 Inhibitor in Cell-Based Assays of Acute Myeloid Leukemia

First agent in a new class of noncytotoxic cancer drugs

January 9, 2019/Basic & Translational Science/Research

New Grants Boost Hereditary Breast and Ovarian Cancer Research

Understanding resistance in PARP inhibitor therapy

January 4, 2019/Cancer/Tumor Oncology

SELECT Trial Finds TKIs Delay Recurrence but May Not Improve Cure Rate

More time on drug may be needed

BackPage 71 of 88Next